201 related articles for article (PubMed ID: 6386275)
21. The effect of chronic guanfacine administration on high plasma vasopressin levels in essential hypertension.
Berkman K; Tözün N; Taga Y; Dedeoğlu A; Onat F; Bekiroğlu N
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):67-71. PubMed ID: 2407671
[TBL] [Abstract][Full Text] [Related]
22. Guanfacine and other centrally acting drugs in antihypertensive therapy; pharmacological and clinical aspects.
Saameli K; Jerie P; Scholtysik G
Clin Exp Hypertens A; 1982; 4(1-2):209-19. PubMed ID: 6280899
[TBL] [Abstract][Full Text] [Related]
23. Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Am J Cardiol; 1986 Mar; 57(9):27E-31E. PubMed ID: 3513527
[TBL] [Abstract][Full Text] [Related]
24. Guanfacine: effects of long-term treatment and withdrawal.
Reid JL; Zamboulis C; Hamilton CA
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
[TBL] [Abstract][Full Text] [Related]
25. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
[TBL] [Abstract][Full Text] [Related]
26. [Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].
Muga R; Tor J; Forteza-Rei J; Jacas C; Altés J; Mestre L
Med Clin (Barc); 1990 Feb; 94(5):169-72. PubMed ID: 1969980
[TBL] [Abstract][Full Text] [Related]
27. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
28. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of guanfacine in essential hypertension.
Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
Szám I; Kállay K
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
Keenan RE; Black PL; Freudenburg JC; Hill JA; Holmburg CE; Reitbrock MJ; Sullivan MJ; Thompson MT; Wright DL
Am J Cardiol; 1986 Mar; 57(9):38E-42E. PubMed ID: 3513529
[TBL] [Abstract][Full Text] [Related]
33. [Central hypotensive effects of guanfacine in anaesthetised rabbits (author's transl)].
Ohkubo K; Suzuki K; Oguma M; Otorii T
Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):263-74. PubMed ID: 7047324
[TBL] [Abstract][Full Text] [Related]
34. The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats.
Salzmann R
J Pharm Pharmacol; 1979 Apr; 31(4):212-6. PubMed ID: 36458
[TBL] [Abstract][Full Text] [Related]
35. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
Materson BJ; Kessler WB; Alderman MH; Canosa FL; Finnerty FA; Savran SV; McMillen JI; Marlon AM
Am J Cardiol; 1986 Mar; 57(9):32E-37E. PubMed ID: 3513528
[TBL] [Abstract][Full Text] [Related]
36. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
[TBL] [Abstract][Full Text] [Related]
37. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
Rosenthal J; Schäfer N; Rauh J; Raschig A
Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
[TBL] [Abstract][Full Text] [Related]
38. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
39. Hemodynamic effects of loud noise before and after central sympathetic nervous stimulation.
Eggertsen R; Svensson A; Magnusson M; Andrén L
Acta Med Scand; 1987; 221(2):159-64. PubMed ID: 2884813
[TBL] [Abstract][Full Text] [Related]
40. Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline.
Zamboulis C; Reid JL
Eur J Clin Pharmacol; 1981 Jan; 19(1):19-24. PubMed ID: 7007059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
